Identification of a high FOXA1-induced pro-metastatic enhancer signature in endocrine-resistant and metastatic breast cancer

被引：0
|
作者：
Fu, Xiaoyong [1 ]
Pereira, Resel [1 ]
De Angelis, Carmine [1 ]
Nanda, Sarmistha [1 ]
Qin, Lanfang [1 ]
Veeraraghavan, Jamunarani [1 ]
Selenica, Pier [2 ]
Weigelt, Britta [2 ]
Reis-Filho, Jorge S. [2 ]
Nardone, Agostina [3 ]
Jeselsohn, Rinath [3 ]
Brown, Myles [3 ]
Rimawi, Mothaffar F. [1 ]
Osborne, Ckent [1 ]
Schiff, Rachel [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-PD7-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD7-01
引用
收藏
页数：3
相关论文
共 50 条
  • [1] High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer
    Fu, Xiaoyong
    Pereira, Resel
    Liu, Chia -Chia
    De Angelis, Carmine
    Shea, Martin J.
    Nanda, Sarmistha
    Qin, Lanfang
    Mitchell, Tamika
    Cataldo, Maria L.
    Veeraraghavan, Jamunarani
    Sethunath, Vidyalakshmi
    Giuliano, Mario
    Gutierrez, Carolina
    Gyorffy, Balazs
    Trivedi, Meghana, V
    Cohen, Ofir
    Wagle, Nikhil
    Nardone, Agostina
    Jeselsohn, Rinath
    Rimawi, Mothaffar F.
    Osborne, C. Kent
    Schiff, Rachel
    CELL REPORTS, 2023, 42 (08):
  • [2] Integrative cistromic/transcriptomic profiling identifies a high FOXA1/ER-activated pro-metastatic secretome in endocrine-resistant breast cancer
    Fu, Xiaoyong
    Pereira, Resel
    De Angelis, Carmine
    Nanda, Sarmistha
    Qin, Lanfang
    Shea, Martin J.
    Mitchell, Tamika
    Veeraraghavan, Jamunarani
    Sethunath, Vidyalakshmi
    Gutierrez, Carolina
    Gyorffy, Balazs
    Cohen, Ofir
    Wagle, Nikhil
    Nardone, Agostina
    Jeselsohn, Rinath
    Brown, Myles
    Rimawi, Mothaffar F.
    Osborne, C. Kent
    Schiff, Rachel
    CANCER RESEARCH, 2020, 80 (04)
  • [3] FOXA1 induces a pro-metastatic secretome through ER-dependent and independent transcriptional reprogramming in endocrine-resistant breast cancer
    Fu, X.
    Pereira, R.
    Zhao, D.
    Jung, S. Y.
    Jeselsohn, R.
    Creighton, C. J.
    Shea, M.
    Nardone, A.
    Angelis, C. D.
    Tsimelzon, A.
    Wang, T.
    Gutierrez, C.
    Huang, S.
    Edwards, D. P.
    Rimawi, M. F.
    Hilsenbeck, S. G.
    Brown, M.
    Chen, K.
    Osborne, C. K.
    Schiff, R.
    CANCER RESEARCH, 2017, 77
  • [4] The genomic landscape of endocrine-resistant metastatic breast cancer
    Razavi, P.
    CANCER RESEARCH, 2020, 80 (04)
  • [5] FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer
    Fu, Xiaoyong
    Pereira, Resel
    De Angelis, Carmine
    Veeraraghavan, Jamunarani
    Nanda, Sarmistha
    Qin, Lanfang
    Cataldo, Maria L.
    Sethunath, Vidyalakshmi
    Mehravaran, Sepideh
    Gutierrez, Carolina
    Chamness, Gary C.
    Feng, Qin
    O'Malley, Bert W.
    Selenica, Pier
    Weigelt, Britta
    Reis-Filho, Jorge S.
    Cohen, Ofir
    Wagle, Nikhil
    Nardonek, Agostina
    Jeselsohn, Rinath
    Brown, Myles
    Rimawi, Mothaffar F.
    Osborne, C. Kent
    Schiff, Rachel
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (52) : 26823 - 26834
  • [6] Targeting the FRA1-dependent transcriptional nexus in high FOXA1-driven endocrine-resistant and metastatic breast cancer
    Liu, Chia Chia
    Qin, Lanfang
    De Angelis, Carmine
    Nanda, Sarmistha
    Pereira, Resel
    Shea, Martin J.
    Nardone, Agostina
    Jeselsohn, Rinath
    Cohen, Ofir
    Wagle, Nikhil
    Liu, Zhijie
    Rimawi, Mothaffar F.
    Osborne, C. Kent
    Schiff, Rachel
    Fu, Xiaoyong
    CANCER RESEARCH, 2022, 82 (04)
  • [7] A FOXA1/FRA1-centered transcriptional axis regulates interferon signaling in high FOXA1-associated endocrine-resistant and metastatic breast cancer
    Fu, Xiaoyong
    Pereira, Resel
    Qin, Lanfang
    De Angelis, Carmine
    Nanda, Sarmistha
    Shea, Martin
    Nardone, Agostina
    Jeselsohn, Rinath
    Cohen, Ofir
    Wagle, Nikhil
    Rimawi, Mothaffar
    Osborne, C. Kent
    Schiff, Rachel
    CANCER RESEARCH, 2021, 81 (04)
  • [8] Hyperactive FOXA1 activates super-enhancer-engaged HIF2α/EPAS1 to promote endocrine-resistant metastatic ER-positive breast cancer
    Fu, Xiaoyong
    Pereira, Resel
    De Angelis, Carmine
    Veeraraghavan, Jamunarani
    Shea, Martin J.
    Nanda, Sarmistha
    Feng, Qin
    Jeselsohn, Rinath
    O'Malley, Bert W.
    Brown, Myles
    Osborne, C. Kent
    Schiff, Rachel
    CANCER RESEARCH, 2018, 78 (04)
  • [9] Possible involvement of prolactin in endocrine-resistant metastatic prostate cancer
    Lissoni, P
    Bignami, A
    Frontini, L
    Manganini, V
    Dapretto, E
    Gardani, GS
    Viganò, P
    Strada, G
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2005, 20 (02): : 123 - 125
  • [10] A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancer
    Trinh, X. B.
    Sas, L.
    Van Laere, S. J.
    Prove, A.
    Deleu, I.
    Rasschaert, M. A.
    Van de Velde, H.
    Vinken, P.
    Vermeulen, P. B.
    van Dam, P. A.
    Wojtasik, A.
    De Mesmaeker, P.
    Tjalma, W. A.
    Dirix, L. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345